Damien Fraysse

This inventor holds 46 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 17 EPO patents, primarily in Kinase Inhibitors. Top assignees: Vertex Pharmaceuticals, Inc., Merck Patent Gmbh, Other. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Damien Fraysse. Retrieved from https://idiyas.com/inventor/damien-fraysse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 46 (Patent Applications = 16)

% Patents Active = 67.4

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 17 (Patent Applications = 25)

Average Co-Inventor Count = 10.0

ph-index = 18

Forward Citations = 635(Granted Patents)

Location History:

Oxfordshire, GB (2010)
Abingdon, GB (2009 - 2024)

Company Filing History:

45 out of 1,167

Vertex Pharmaceuticals, Inc.

1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

ATR Kinase

GCN2 Inhibitors

Pyrazolopyridine

Tri-Cyclic Compounds

Aminopyridine

Azaindoles

Pyrazolopyrazine

Amino Substituted Pyridines

JAK Inhibitors

Protein Kinases

Kinase Inhibitors

Aminopyrimidines

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187731 - Compounds useful as inhibitors of ATR kinase (2025-01-07),

2. 12084438 - GCN2 inhibitors and uses thereof (2024-09-10),

3. 11485739 - Compounds useful as inhibitors of ATR kinase (2022-11-01),

4. 11370798 - Compounds useful as inhibitors of ATR kinase (2022-06-28),

5. 11117900 - Compounds useful as inhibitors of ATR kinase (2021-09-14),

6. 10988477 - GCN2 inhibitors and uses thereof (2021-04-27),

7. 10815239 - Compounds useful as inhibitors of ATR kinase (2020-10-27),

8. 10800781 - Compounds useful as inhibitors of ATR kinase (2020-10-13),

9. 10793563 - GCN2 inhibitors and uses thereof (2020-10-06),

10. 10787452 - Compounds useful as inhibitors of ATR kinase (2020-09-29),

11. 10392391 - Compounds useful as inhibitors of ATR kinase (2019-08-27),

12. 10160760 - Compounds useful as inhibitors of ATR kinase (2018-12-25),

13. 10093676 - Compounds useful as inhibitors of ATR kinase (2018-10-09),

14. 9718827 - Compounds useful as inhibitors of ATR kinase (2017-08-01),

15. 9670215 - Compounds useful as inhibitors of ATR kinase (2017-06-06),

Title: Damien Fraysse - Innovative Inventor from Abingdon, GB

Introduction: Damien Fraysse is a talented inventor hailing from Abingdon, Great Britain, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Damien Fraysse holds several patents in the areas of renewable energy technologies, smart home devices, and sustainable transportation solutions, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Damien Fraysse has worked with leading tech companies to develop cutting-edge products that have revolutionized various industries. His commitment to pushing the boundaries of innovation has earned him recognition as a visionary in the field.

Collaborations: Throughout his career, Damien Fraysse has collaborated with top researchers, engineers, and designers to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful development of numerous groundbreaking inventions.

Conclusion: Damien Fraysse's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on the world of technology is undeniable, and his legacy is sure to endure for years to come.

Profile summary based on public USPTO records.